Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: Implications for early recognition of patients with poor response to anti-tuberculosis treatment

AIDS

Volumn 13, Issue 8, 1999, Pages 935-941

  Hsieh, Szu Min ^a   Hung, Chien Ching ^a   Chen, Mao Yuan ^a   Sheng, Wang Huei ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AIDS; Surrogate marker; Tuberculosis; Tumour necrosis factor

Indexed keywords

CD4 ANTIGEN; CYTOKINE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; LONGITUDINAL STUDIES; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033007830     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905280-00009     Document Type: Article

References (16)

1. Bloom BR, Small PM. The evolving relation butween human and Mycobacterium tuberculosis. N Engl J Med 1998, 338:677-678.
2. Kramer F, Modilevskey T, Waliany AR, Leedom JM, Barnes PF. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990, 89:451-456.
3. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997, 24:661-668.
4. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis 1995, 21:1245-1252.
5. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994, 149:1359-1374.
6. th Edn. Edited by Fauci AS, Braunwald E, Isselbacher KJ, et al. New York: McGraw-Hill; 1998:1004-1014.
7. Hsieh SM, Hung CC, Chen MY, Hsueh PR, Chang SC, Luh KT. Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan. AIDS 1998, 12:1301-1307.
8. Ellner JJ. The immune response in human tuberculosis - implications for tuberculosis control. J Infect Dis 1997, 176:1351-1359.
9. Hynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572.
10. th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, September Ocober 1997 [abstract G-27].
11. Juffermans N, Verbon A, van Deventer SJH, van Deutekom H, Spellman P, van der Poll T. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 1998, 157:1328-1331.
12. Bekker LG, Maartens G, Steyn L, Kaplan G. Selective increase in plasma tumor necrosis factor-α and concomitant clinical deterioration after initiating therapy in patienls with severe tuberculosis. J Infect Dis 1998, 178:580-584.
13. Bajaj G, Rattan A, Ahmad P. Prognostic value of C-reactive protein in tuberculosis. Ind Pediatr 1989, 26:1010-1013.
14. th Edn. Edited by Balows A, Hausier Jr WJ, Herrmann KL, Isenberg HD, Shadomy HJ. Washington, DC: American Society for Microbiology; 1991:304-339.
15. Telzak EE, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995, 333:907-911.
16. Drobniewski FA, Pozniak AL. Molecular diagnosis, detection of drug resistance and epidemiology of tuberculosis. Br J Hosp Med 1996, 56:204-208.